Back to User profile » Dr Francesca Li Gobbi
Papers published by Dr Francesca Li Gobbi:
Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data
Benucci M, Damiani A, Li Gobbi F, Grossi V, Infantino M, Manfredi M, Niccoli L, Cantini F
Therapeutics and Clinical Risk Management 2020, 16:287-297
Published Date: 16 April 2020
Abatacept: from a budget impact model to cost-effectiveness analysis – data from RCT and real life
Benucci M, Damiani A, Manfredi M, Infantino M, Grossi V, Li Gobbi F
ClinicoEconomics and Outcomes Research 2019, 11:405-409
Published Date: 7 June 2019
Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables
Niccoli L, Nannini C, Blandizzi C, Mantarro S, Mosca M, Di Munno O, Goletti D, Benucci M, Li Gobbi F, Cassarà E, Kaloudi O, Cantini F
Therapeutics and Clinical Risk Management 2018, 14:2097-2111
Published Date: 24 October 2018
Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis
Benucci M, Bandinelli F, Damiani A, Li Gobbi F, Infantino M, Grossi V, Manfredi M
Journal of Inflammation Research 2018, 11:247-252
Published Date: 7 June 2018
Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases
Benucci M, Damiani A, Li Gobbi F, Bandinelli F, Infantino M, Grossi V, Manfredi M, Noguier G, Meacci F
Biologics: Targets and Therapy 2018, 12:37-41
Published Date: 31 January 2018